Specialty code 1835P0018X · Huntersville, NC
NPI
1285239129
Since 2020
Specialty
Specialty code 1835P0018X
Code 1835P0018X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
16525 Holly Crest Ln Ste 230
Huntersville, NC, 28078
Phone (704) 316-6360
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$941K
1,298 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Kimberly R Hayashi prescribed most often to Medicare patients was Jardiance (Empagliflozin), with 145 prescriptions and refills. In total Kimberly R Hayashi wrote 1,298 Medicare prescriptions that cost $941K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-10.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Jardiance Empagliflozin | 145 | 362 | 50 | $206K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 124 | 269 | 44 | $20K |
| Ozempic Semaglutide | 81 | 127 | 38 | $119K |
| Novolog Flexpen Insulin Aspart | 77 | 153 | 28 | $19K |
| Mounjaro Tirzepatide | 64 | 80 | 24 | $84K |
| Humalog Kwikpen U-100 Insulin Lispro | 64 | 152 | 26 | $22K |
| Farxiga Dapagliflozin Propanediol | 53 | 131 | 15 | $73K |
| Tresiba Flextouch U-100 Insulin Degludec | 36 | 115 | 17 | $33K |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 34 | 73 | 13 | $39K |
| Techlite Pen Needle Pen Needle, Diabetic | 32 | 73 | 13 | $1,505 |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 31 | 75 | 12 | $3,783 |
| Tresiba Flextouch U-200 Insulin Degludec | 30 | 62 | 12 | $29K |
| Levothyroxine Sodium Generic | 28 | 49 | Under 11 | $61.04 |
| Metformin Hcl Er Metformin Hcl | 26 | 62 | 12 | $275 |
| Victoza 3-Pak Liraglutide | 24 | 36 | Under 11 | $28K |
Brand drugs: 995 claims; generic drugs: 128 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Kimberly R Hayashi were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.